Our primary research focus is on synaptic molecules such as Neurexin/Neuroligin,
CASK, and IQSEC2. These molecules play a regulatory role in information
transmission between nerve cells, and their functional abnormalities have
been implicated in neurodevelopmental disorders. Neurexin/Neuroligin interact
at the pre- and post-synaptic membranes, playing crucial roles in synaptic
stabilization and functional regulation. Deficiencies or functional abnormalities
in these molecules affect the formation and function of neural circuits
and have been associated with neurodevelopmental disorders, such as autism
spectrum disorder (ASD). CASK is a multifunctional protein involved in
the formation and regulation of synaptic functions, and its genetic mutations
have been linked to intellectual disabilities and developmental delays.
IQSEC2 controls GTPase activated to regulate synaptic plasticity, and its
abnormalities have been implicated as causes of intellectual disabilities
and epilepsy. Through these studies, our laboratory aims to elucidate the
pathogenesis of neurodevelopmental disorders caused by synaptic molecules.
Furthermore, these findings are expected to contribute to the development
of new therapeutic strategies. Our laboratory actively pursues these objectives
and strives to discover further insights. We also hope that our research
findings will contribute to a better understanding and improvement of treatment
methods for neurodevelopmental disorders. 3-1-1 Asahi, Matsumoto,
Nagano 390-8621
Japan
PHONE: +81-263-37-3775
FAX: +81-263-37-3776
E-mail: ktabuchi@shinshu-u.ac.jp